Komori
COSMOS Pharmaceutical (3349) · FactRecognition of compensation received updated

Compensation for Store Relocation Associated with Road-Widening Works

First written in FY2023-Q2. . Latest entry: FY2026.

5entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2023-Q2 – FY20262023: 220232024: 220242025: 020252026: 12026
Same theme, other companies
Recognition of Compensation IncomeA theme 77 companies write about · 0 as a headwind · 80 as a tailwind

The whole theme swung hardest in 2018: 1 of 9 companies on the "Worse" side.

34 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 77 companies compared. The sentences above are computed from all 77.
Full recordFilings, disclosures and news, newest first
  1. FY2026Recognition of compensation received updatedAnnual report

    「This relates to relocation compensation for stores, fixtures and other assets associated with the Yakiyama-Oshikomi Line urban planning road project being constructed by Hiroshima Prefecture.」

    ¥42 million in compensation received was recorded as extraordinary income for relocation compensation for stores, fixtures and other assets associated with a Hiroshima Prefecture road project.
  2. FY2024Confirmation of full-year recognition of compensation receivedAnnual report

    「The compensation received comprises compensation for the relocation of store fixtures and other property in connection with National Route 442 road improvement work in Oita Prefecture, among other items.」

    For the full year, ¥552 million in compensation received was recorded in connection with relocation compensation for stores, fixtures and other assets associated with road improvement works.
  3. FY2024-Q3Recognition of compensation received updatedAnnual report

    「The compensation received comprises compensation for the relocation of store fixtures and other property in connection with National Route 442 road improvement work in Oita Prefecture, among other items.」

    The company recognized ¥403 million in compensation received as extraordinary income, representing compensation for the relocation of store fixtures and other property in connection with National Route 442 road improvement work in Oita Prefecture, among other items.
  4. FY2023Compensation income recognized for the full yearAnnual report

    「The compensation received consisted of relocation compensation for store fixtures and other property in connection with road-widening projects in Wakayama Prefecture and Shiso City, Hyogo Prefecture.」

    The company recognized full-year compensation received of ¥33 million as relocation compensation for store fixtures and other property in connection with road expansion work.
  5. FY2023-Q2First statedAnnual report

    「The compensation received consisted of relocation compensation for store fixtures and other property in connection with road-widening projects in Wakayama Prefecture and Shiso City, Hyogo Prefecture.」

    The company recorded ¥26 million in extraordinary income as relocation compensation for store fixtures and other property related to road-widening projects in Wakayama Prefecture and Shiso City, Hyogo Prefecture.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for COSMOS Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.